Thrombospondin-1 (TSP1) can inhibit angiogenesis by interacting with endoth
elial cell CD36 or proteoglycan receptors. We have now identified alpha 3 b
eta 1 integrin as an additional receptor for TSP1 that modulates angiogenes
is and the in vitro behavior of endothelial cells. Recognition of TSP1. and
an alpha 3 beta 1 integrin-binding peptide from TSP1 by normal endothelial
cells is induced after loss of cell-cell contact or ligation of CD98. Alth
ough confluent endothelial cells do not spread on a TSP1 substrate, alpha 3
beta 1 integrin mediates efficient spreading on TSP1 substrates of endothe
lial cells deprived of cell-cell contact or vascular endothelial cadherin s
ignaling. Activation of this integrin is independent of proliferation, but
ligation of the alpha 3 beta 1 integrin modulates endothelial cell prolifer
ation. In solution, both intact TSP1 and the alpha 3 beta 1 integrin-bindin
g peptide from TSP1 inhibit proliferation of sparse endothelial cell cultur
es independent of their CD36 expression. However, TSP1 or the same peptide
immobilized on the substratum promotes their proliferation. The TSP1 peptid
e, when added in solution, specifically inhibits endothelial cell migration
and inhibits angiogenesis in the chick chorioallantoic membrane, whereas a
fragment of TSP1 containing this sequence stimulates angiogenesis. Therefo
re, recognition of immobilized TSP1 by alpha 3 beta 1 integrin may stimulat
e endothelial cell proliferation and angiogenesis. Peptides that inhibit th
is interaction are a novel class of angiogenesis inhibitors.